Using a portable ion mobility spectrometer to screen dietary supplements for sibutramine

Jamie D Dunn1, Connie M Gryniewicz-Ruzicka, John F Kauffman

  • 1Food and Drug Administration, Division of Pharmaceutical Analysis, 1114 Market St., St. Louis, MO 63101, United States. Jamie.Dunn@fda.hhs.gov

Summary

A new method detects undeclared sibutramine in supplements using portable ion mobility spectrometry in just 15 seconds. This technique offers a rapid screening tool for regulatory agencies to ensure product safety.

Related Concept Videos